Brief: Purapharm Corp Sees HY Unaudited Consol Net Loss Of Not More Than HK$20 Mln
16/08/2024 15:31
Aug 16 (Reuters) - PuraPharm Corp Ltd 1498.HK :
* PURAPHARM CORP LTD SEES HY UNAUDITED CONSOL NET LOSS OF
NOT MORE
THAN HK$20 MILLION
* EXPECTED RESULT DUE TO REDUCTION IN ADMINISTRATIVE
EXPENSES,
AMONG OTHERS
Further company coverage: 1498.HK
Recent news on PuraPharm
See all newsBrief: Purapharm Corp To Issue Convertible Bonds With Principal Amount Of HK$20 MLN
Brief: Purapharm Corp To Issue Consideration Shares As Licence Fee
Brief: Purapharm Says Kam Biu Tsoi, Alvin Appointed As Executive Director
Brief: Purapharm Corp Announces Lapse Of Disposal Agreement
Brief: PuraPharm Corp To Dispose Of Accounts Receivables At HK$15 Mln